Overland Park, KS, United States of America

Gary Lee Silvey



Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 174(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Gary Lee Silvey: Innovator in Pharmaceutical Formulations

Introduction

Gary Lee Silvey is a notable inventor based in Overland Park, KS (US), recognized for his contributions to pharmaceutical formulations. With a total of 12 patents, Silvey has made significant advancements in the field of medicine, particularly in the development of innovative drug compositions.

Latest Patents

Among his latest patents, Silvey has developed a fexofenadine suspension formulation, which is an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I. This invention aims to improve the delivery and efficacy of the medication. Additionally, he has worked on pharmaceutical compositions comprising 5-azacytidine monohydrate, which are designed for oral administration in the treatment of diseases, including myelodysplastic syndromes (MDS).

Career Highlights

Throughout his career, Gary Lee Silvey has been associated with prominent companies in the pharmaceutical industry, including Pharmion Corporation and Ash Stevens, Inc. His work has focused on creating effective and innovative solutions for various medical conditions, showcasing his dedication to improving patient care.

Collaborations

Silvey has collaborated with esteemed professionals in the field, including Dumitru Ionescu and Peter Blumbergs. These partnerships have contributed to the success of his inventions and the advancement of pharmaceutical science.

Conclusion

Gary Lee Silvey's contributions to pharmaceutical formulations highlight his innovative spirit and commitment to enhancing medical treatments. His work continues to impact the industry positively, making him a significant figure in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…